Investigating how specific antibodies contribute to multiple sclerosis
Contribution of antibodies targeting PLP1-anchored membrane domains to multiple sclerosis pathogenesis
This study is looking at how certain immune cells and the antibodies they make might play a role in multiple sclerosis, and it’s for people with MS who want to understand more about how their condition affects their nerves and what new treatments might be on the horizon.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10981025 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of B-cells and the antibodies they produce in the development of multiple sclerosis (MS). By analyzing antibodies from patients with MS, researchers aim to identify how these antibodies interact with myelin and contribute to nerve damage. The study employs advanced techniques to produce and test recombinant antibodies, which mimic those found in patients, to explore their effects on oligodendrocytes, the cells responsible for myelin maintenance. The findings could provide insights into the mechanisms of MS and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis, particularly those with active disease.
Not a fit: Patients with other neurological disorders or those without a diagnosis of multiple sclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the harmful antibodies involved in multiple sclerosis.
How similar studies have performed: Previous studies have shown promising results in understanding the role of B-cells in multiple sclerosis, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Bennett, Jeffrey L — University of Colorado Denver
- Study coordinator: Bennett, Jeffrey L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.